ALTANA strengthens its portfolio of testing and measuring instruments with a strategic acquisition
Acquisition of the business of Imaginant, the leading international specialist for ultrasonic measuring equipment
ALTANA has acquired the business of Imaginant Inc., a U.S. company that develops and manufactures test and measurement instruments based on ultrasound. With this acquisition, the specialty chemicals group has strategically expanded its BYK division and entered the growth market of the semiconductor industry. Imaginant is based in New York State and will be integrated into BYK-Gardner.
The U.S. company's test and measurement instruments are used for quality assurance in many industrial applications. For example, these instruments make it possible to determine the thickness of multilayer automotive and other coatings through nondestructive testing. In the semiconductor industry, Imaginant’s devices are used in scanning acoustic microscopes for the detection of delamination, cracks, and cavities inside electronic components.
Integration of measurement technology in BYK software solutions
As part of the acquisition, BYK is also taking over the production facility located in Rochester, New York. With a total of 34 employees, the company, founded in 1986, supplies its products to customers on all continents.
“Imaginant’s technological expertise in the development and manufacturing of high-frequency ultrasonic measuring instruments complements BYK-Gardner’s strengths as a specialist in innovative high-tech instruments for testing color, gloss, and physical properties,” says Dr. Tammo Boinowitz, a member of the Management Board of ALTANA AG and the president of the BYK division. “By integrating these measurement technologies into our software and services, we intend to further simplify our customers’ production processes and drive the digitalization of the industry."
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Chemists develop MRI-like technique to detect what ails batteries
New corona mass test up to 100 times more sensitive than rapid antigen tests - The innovative corona test "LAMP-Seq"
A more complete picture of the nano world
Nimbus Discovery and Proteros enter into multi-target X-ray protein crystallography collaboration
Lab901 and Biofortuna to collaborate on automated PCR Dx for HLA and Coeliac disease
Mode of action of the vaccine adjuvant flagellin in fusion proteins has been clarified
Alternative methods replace animal experiments: 20 years successful work by ZEBET within BfR - ZEBET celebrates its anniversary with an international symposium at BfR in Berlin
Imaging the smallest atoms provides insights into an enzyme's unusual biochemistry - This could help in the design of enzymes for the chemical industry